Objectives: This study investigated changes in health-related quality of life (QOL) in patients treated for pararenal (PRA) and thoracoabdominal aortic aneurysms (TAAAs) with fenestrated-branched endovascular aortic repair (F-BEVAR).
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Clinical Trial and Real-World Outcomes of Endovascular Iliac Aneurysm Repair With the Gore Iliac Branch Endoprosthesis (IBE)
Objectives: The purpose of this study was to determine the midterm effectiveness of endovascular iliac artery aneurysm repair with hypogastric artery preservation using the Iliac Branch Endoprosthesis (IBE; W. L. Gore, Flagstaff, Ariz) in both multicenter trial and "real-world" use settings.
Methods: All patients who underwent treatment of iliac artery aneurysms with the IBE device as subjects in the pivotal IBE 12-04 prospective United States multicenter study and the Global Registry for Endovascular Aortic Treatment (GREAT) prospective multicenter international registry study between 2013 and 2015 were included. Pooled and side-by-side comparisons of outcomes through 3 years of follow-up were analyzed. Data were analyzed for procedural success, overall survival, iliac patency, reinterventions, and incidence of new-onset buttock claudication or sexual dysfunction.
Results: A total of 190 patients underwent treatment with 207 IBE device (s), including 98 patients in IBE 12-04 (pivotal study cohort, n ¼ 63; and continued access cohort, n ¼ 35) and 92 patients in GREAT. Seventeen patients (8.9%) underwent bilateral IBE device placement. The GREAT cohort included more females (n ¼ 7.6% vs n ¼ 1.0%; P ¼ .03), more nonwhites (25.9% vs 11.1%; P < .001), and the patients were older (mean age, 72.7 6 7.7 vs 69.0 6 9.3 years; P < .011) than in the IBE 12-04 cohort. However, mean common iliac aneurysm diameters were similar (IBE 12-04: 39.3 6 10.9 mm; GREAT: 36.6 6 11.0 mm). In GREAT, 62% of were treated outside of instructions for use guidelines and would not have met inclusion/exclusion criteria for the IBE 12-4 study. Procedural survival was 100% in both cohorts. Mean follow-up was 537 days for IBE 12-04 and 225 days for GREAT. All-cause mortality was 6.1% in IBE 12-04 and 5.4% in GREAT. Device-related reinterventions occurred in 8.2% for IBE 12-04 and 4.3% for GREAT. The incidence of hypogastric or external iliac artery occlusion was 8.2% for IBE 12-04 and 1.1% for GREAT, with no reports of new-onset buttock claudication or sexual dysfunction in either study cohort.
Conclusions: Endovascular repair of iliac artery aneurysms with hypogastric artery preservation using the IBE device was effective, with good midterm outcomes in both multicenter trial and real-world settings. Through 3 years of follow-up in both settings, the incidence of ischemic complications, device occlusion, and need for reintervention remains low and support the treatment of iliac aneurysms with iliac branch devices. Objectives: Iliac artery aneurysms (IAA) associated with aortic aneurysms can complicate their management. The aim of this study was to evaluate the incidence, management, and outcomes of IAA associated with juxtarenal (JRAA) and thoracoabdominal aortic aneurysms (TAAA) treated with fenestrated/branched aortic endografts (F/B-EVAR).
Methods: Data from 1118 patients (Table) enrolled in a physician-sponsored investigational device exemption trial (2001-2016) for treatment of JRAA or TAAA with F/B-EVAR were evaluated. Maximum iliac artery diameter was determined by an imaging core laboratory, and IAAs were defined as $21 mm in diameter. Clinical management, perioperative outcomes, and long-term outcomes were analyzed. Data are presented as mean 6 standard deviation and were assessed using KaplanMeier, univariate, and multivariable analysis.
Results: Of 364 (33%) patients with IAA, 219 (60%) were unilateral and 145 (40%) were bilateral. Of the 509 IAA, 234 (46%) were treated with an iliac limb without coverage of the hypogastric artery, 103 (20%) had hypogastric artery coverage, 105 (21%) had placement of a hypogastric branched endograft (HBE), and 67 (13%) went untreated. Procedure duration was longer for those with IAA (5.3 6 1.79 vs 4.6 6 1.74 hours; P < .001), although hospital stay was not. Hazards of aneurysm-related mortality and all-cause mortality trended higher in unilateral and bilateral IAA groups. Treatment with a HBE had lower hazards of death than those without (adjusted for age, procedure duration, and repair class (HR 0.64, P ¼ .017). Hazards of reintervention were higher in those with unilateral and bilateral IAA compared to no IAA (hazard ratio [HR], 1.45 and 2.09, respectively), but was not associated with the use of HBE. Spinal cord ischemia trended higher in unilateral and bilateral IAA than no IAA (HR 2.59 and 12.96; P ¼ .259 and P ¼ .056, respectively).
Conclusions: Patients with unilateral and bilateral IAA comprised a substantial portion of those who underwent F/B-EVAR for JRAA and TAAAs. The complexity of the disease is supported by trends toward higher hazards of aneurysm-related mortality, all-cause mortality, reintervention, and spinal cord ischemia in patients with IAA compared to those with no IAA. Lower hazards of death were found in those treated for IAA with a hypogastric branch, with no difference in reintervention detected. These results suggest that F/B-EVAR including hypogastric branch may be a robust treatment option for complex patients with TAAA and concomitant IAA. Additional efforts are needed to improve outcomes and understand the utility of this treatment option for this complex subset of the TAAA population.
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Flexible Stents Improve Renal Artery Branch Patency After Multibranched Endovascular Aortic Aneurysm Repair
Warren Gasper, MD, Smita Kaushik, MD, Linda M. Reilly, MD, Jade S. Hiramoto, MD, Timothy Chuter, MD. University of California, San Francisco, Calif
Objectives: Technical and short-term success with multibranched endovascular thoracoabdominal aortic aneurysm (TAAA) repairs (MBE-VAR) is now routine. However, late branch occlusion, particularly renal branch occlusion, is a stubborn source of morbidity in the mid-to lateterm. The aim of this study was to investigate the effect of renal branch stent type on midterm renal branch occlusion rates after MBEVAR of TAAA and pararenal aortic aneurysms (PRAA).
Methods: From July 2005 to October 2016, 143 patients underwent elective MBEVAR for TAAA and PRAA with at least one renal artery branch constructed of self-expanding stents from the native renal artery to the device cuff. In 2013, an analysis of branch morphology suggested more flexible branches would perform better, so our preferred renal branch configuration switched from a Fluency + Wallstent (FW) to a Viabahn + Zilver (VZ) combination. Data on demographics, operative repair, complications, and outcomes were collected prospectively.
Results: The mean patient age was 73 6 7.7 years, 109 (76%) were men, and the mean aneurysm diameter was 66.8 6 9.1 mm. There were 266 renal branches placed, of which 158 (59.4%) were FW, 56 (21.1%) were VZ, and 52 (19.5%) were other combinations. There were no significant differences in age, sex, preoperative aneurysm diameter, Crawford aneurysm classification, medical comorbidities, or baseline renal function between patients with FW vs VZ renal branches. There was also no significant difference in native renal 
